id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-N-1021-0083,FDA,FDA-2012-N-1021,Instructions for Submitting Comments on the CDRH Fiscal Year 2023 Proposed Guidance Development,Other,Additional Information,2022-10-17T04:00:00Z,2022,10,2022-10-17T04:00:00Z,2022-12-17T04:59:59Z,2022-12-17T02:00:45Z,,0,0,0900006485412672